LTFS
GSK icon

Ladenburg Thalmann Financial Services’s GSK GSK Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$9.19M Sell
157,367
-530
-0.3% -$29.5K 0.06% 318
2019
Q3 		$8.42M Sell
157,897
-2,137
-1% -$110K 0.06% 318
2019
Q2 		$8.03M Buy
160,034
+8,168
+5% +$410K 0.06% 320
2019
Q1 		$7.93M Buy
151,866
+11,371
+8% +$568K 0.06% 305
2018
Q4 		$6.71M Buy
140,495
+9,440
+7% +$465K 0.06% 288
2018
Q3 		$6.58M Buy
131,055
+1,035
+0.8% +$52.6K 0.06% 311
2018
Q2 		$6.35M Hold
130,020
– – 0.06% 297
2018
Q1 		$6.35M Buy
130,020
+2,979
+2% +$139K 0.06% 297
2017
Q4 		$5.64M Sell
127,041
-4,014
-3% -$185K 0.05% 320
2017
Q3 		$6.66M Sell
131,055
-3,579
-3% -$182K 0.07% 252
2017
Q2 		$7.26M Buy
134,634
+1,434
+1% +$76.4K 0.09% 218
2017
Q1 		$7.02M Sell
133,200
-3,963
-3% -$201K 0.09% 211
2016
Q4 		$6.61M Sell
137,163
-12,739
-8% -$629K 0.09% 203
2016
Q3 		$8.08M Sell
149,902
-1,463
-1% -$80.2K 0.12% 169
2016
Q2 		$8.2M Buy
151,365
+5,666
+4% +$298K 0.13% 160
2016
Q1 		$7.38M Buy
145,699
+31,678
+28% +$1.58M 0.13% 166
2015
Q4 		$5.75M Sell
114,021
-5,325
-4% -$271K 0.11% 187
2015
Q3 		$5.72M Buy
119,346
+1,129
+1% +$58.8K 0.12% 171
2015
Q2 		$6.16M Sell
118,217
-2,347
-2% -$132K 0.11% 184
2015
Q1 		$6.96M Buy
120,564
+10,117
+9% +$580K 0.13% 165
2014
Q4 		$5.91M Buy
110,447
+47,443
+75% +$2.65M 0.13% 164
2014
Q3 		$3.62M Buy
63,004
+6,502
+12% +$399K 0.1% 182
2014
Q2 		$3.78M Sell
56,502
-1,093
-2% -$74K 0.1% 169
2014
Q1 		$3.85M Buy
57,595
+1,920
+3% +$130K 0.11% 143
2013
Q4 		$3.72M Buy
55,675
+1,577
+3% +$102K 0.11% 153
2013
Q3 		$3.39M Sell
54,098
-3,155
-6% -$203K 0.12% 155
2013
Q2 		$3.58M Buy
+57,253
New +$3.63M 0.13% 147

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Ladenburg Thalmann Financial Services's GSK Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its GSK (GSK) stake by 0.34% in Q4 2019, selling an estimated $29.5K and leaving 157,367 shares worth $9.19M. The position accounts for 0.06% of the portfolio, ranked #318.

Ladenburg Thalmann Financial Services first reported a position in GSK in Q2 2013 and has held it in 27 quarters since. 894 funds tracked by Wall St. Rank hold GSK as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 157,367 shares of GSK worth $9.19M as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 530 GSK shares in Q4 2019, an estimated $29.5K.
  • GSK made up 0.06% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #318 holding.
  • Ladenburg Thalmann Financial Services first reported a position in GSK in Q2 2013 and has held it in 27 quarters since.
  • 894 funds tracked by Wall St. Rank held GSK as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.